Picture EBD Group World of Partnering Opportunities 650x100px

Person › Details

Jörn Aldag (Hookipa Biotech AG)

Aldag, Jörn (Hookipa Biotech 201606– CEO before Uniqure/AMT + Evotec + MAN GHH)

	Organisation	Hookipa Biotech AG
	Group	Hookipa (Group)
	Former/major organisation	Amsterdam Molecular Therapeutics (AMT) Holding N.V. (Euronext: AMT)
	Today	Uniqure N.V. (Nasdaq: QURE)
	Group	Uniqure (Group)
	Product	vaccine technology
	Product 2	gene therapy

Record changed: 2024-02-06

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Jörn Aldag

[1] Hookipa Pharma Inc.. (1/29/24). "Press Release: Hookipa Pharma Provides Update on Business Priorities and Oncology Partnership Programs". New York, NY & Vienna....
[2] Hookipa Pharma Inc.. (12/21/23). "Press Release: Hookipa Pharma Announces $21.25 Million Equity Investment from Gilead Sciences". New York, NY & Vienna....
[3] Hookipa Pharma Inc.. (2/13/23). "Press Release: Hookipa Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers". New York, NY & Vienna....
[4] Hookipa Pharma Inc.. (1/4/23). "Press Release: Hookipa Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine". New York, NY & Vienna....
[5] Hookipa Pharma Inc.. (10/20/22). "Press Release: Hookipa Announces Strategic Collaboration and License Agreement with Roche to Develop Novel Arenaviral Immunotherapy for KRAS-mutated Cancers". New York, NY & Vienna....
[6] Genespire S.r.l.. (7/30/20). "Press Release: Genespire Appoints Jörn Aldag as Chairman of the Board of Directors". Milan....
[7] Hookipa Pharma Inc.. (7/11/19). "Press Release: Hookipa Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers". New York, NY & Vienna....
[8] Hookipa Pharma Inc.. (5/8/19). "Press Release: Hookipa Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead". New York, NY & Vienna....
[9] Hookipa Pharma Inc.. (4/25/19). "Press Release: Hookipa Appoints David R. Kaufman to its Board of Directors". New York, NY & Vienna....
[10] Hookipa Pharma Inc.. (2/26/19). "Press Release: Hookipa Pharma Raises $37.4 Million (€33.2 Million) in Series D Financing". New York, NY & Vienna....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]